Susan Byrne, Westwood Holdings, shares her top portfolio plays.» Read More
While all eyes watch to see if the Fed will hike rates next week, Deutsche Bank economist Joe LaVorgna explains why he believes Janet Yellen could push the decision to October.
There's a big Fed meeting next week. When the Fed will hike, with Joe Lavorgna, Deutsche Bank, CNBC's Jackie DeAngelis and the Futures Now traders, Scott Nations and Jeff Kilburg, both at the CME.
Wall Street and the tech media were disappointed with the Apple product event, continuing worries of a sales growth slowdown in the coming quarters.
Gold's epic losing streak. What will get gold going? With CNBC's Jackie DeAngelis and the Futures Now traders.
As the Fed appears to move closer to a potential rate hike, emerging markets could take a hit. Here are the companies with the most exposure.
China's slowdown and an ongoing currency war will prevent the Fed from lifting interest rates until 2017, Komal Sri-Kumar said.
Mad Money host Jim Cramer tells you how to construct the perfect portfolio for this market.
Mad Money host Jim Cramer thinks there are plenty of ways to choose whether to buy or sell and explains his top methods.
Mad Money host Jim Cramer has to let his dislike of this type of Wall Street trader known.
Jim Cramer tells you how to construct the perfect portfolio for this market.
The Fast Money traders share their final trades of the day including Yahoo and Oil.
Jeffrey Hirsch, Stock Trader's Almanac, discusses what people should be buying right now. Biotech is one of the strongest spaces, says Hirsch.
How to play Apple's big event, with CNBC's Dominic Chu.
The "Fast Money" traders give you 4 plays following Apple's big event today.
Don't get too excited about the recent recovery in stocks. The formation of death crosses in major indexes suggests the trend is still lower.
Here are the top 5 derivative trading plays off Wednesday's Apple product event.
David Nelson, chief strategist of Belpointe Asset Management, explains why the next leg of the bull market might be just around the corner.
JPMorgan expects another $100 billion in outflows on the back of selling pressure in the coming weeks, Dubravko Lakos-Bujas told CNBC.
CNBC "Halftime Report" trader Jon Najarian bought shares of Bristol Myers after spotting unusual activity in the options market.
Hirtle Callaghan & Co CEO Jon Hirtle sees dislocation in emerging markets and energy, and has the contrarian trade for your portfolio.